4-methoxymethyl-pyrrolidine-2-carboxyl ic acid compounds and derivatives thereof as Hepatitis C Virus inhibitors

Details for Australian Patent Application No. 2005298849 (hide)

Owner Glaxo Group Limited

Inventors Smith, Stephen Allan; Nerozzi, Fabrizio; Hartley, Charles David; Guidetti, Rossella; Haigh, David; Howes, Peter David

Agent Davies Collison Cave

Pub. Number AU-A-2005298849

PCT Pub. Number WO2006/045613

Priority 0423673.3 25.10.04 GB

Filing date 24 October 2005

Wipo publication date 4 May 2006

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/045613 Priority application(s): WO2006/045613

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298854-Dosage form time-lagged of drugs for the therapy of insomnia

2005298840-S-alkyl-sulphenyl protection groups in solid-phase synthesis